Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Universal Technical Institute ( (UTI) ) just unveiled an update.
Universal Technical Institute reported fiscal 2026 first-quarter results on February 4, 2026, with revenue climbing 9.6% to $220.8 million as student enrollment expanded, while net income fell to $12.8 million and adjusted EBITDA dropped 23.5% because of $7.6 million in strategic growth expenses tied to new campuses and program expansions. Management reiterated full-year guidance, citing momentum from new site launches, strengthened liquidity of $233.2 million, and continued investment in curriculum and facilities to scale its North Star strategy and reinforce its positioning as a leading workforce solutions provider.
The most recent analyst rating on (UTI) stock is a Hold with a $31.00 price target. To see the full list of analyst forecasts on Universal Technical Institute stock, see the UTI Stock Forecast page.
Spark’s Take on UTI Stock
According to Spark, TipRanks’ AI Analyst, UTI is a Neutral.
Universal Technical Institute’s overall stock score reflects strong financial performance and positive future growth projections from the earnings call. However, technical indicators suggest bearish momentum, and valuation metrics indicate moderate attractiveness. The company’s strategic investments are expected to drive long-term growth but may temporarily impact profit margins.
To see Spark’s full report on UTI stock, click here.
More about Universal Technical Institute
Universal Technical Institute is a workforce education provider focused on transportation, skilled trades, and healthcare training through its UTI and Concorde segments, targeting employer partnerships to address skilled labor needs.
Average Trading Volume: 724,825
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.59B
Find detailed analytics on UTI stock on TipRanks’ Stock Analysis page.